Clinical Trials Browser

Phase 2 × Leukemia, Myeloid, Accelerated Phase × Dasatinib × Clear all

NCT00101647 2011-04-15

Study of Dasatinib (BMS-354825) in Patients With Accelerated Phase Chronic Myeloid Leukemia

Phase 2 Completed

197 enrolled 25 charts

MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Accelerated Phase